Published in Gut on November 01, 2004
The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol (2012) 3.88
Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nat Rev Microbiol (2010) 3.45
Genes and molecules of lactobacilli supporting probiotic action. Microbiol Mol Biol Rev (2008) 3.12
Intestinal bacteria and the regulation of immune cell homeostasis. Annu Rev Immunol (2010) 2.85
Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria. World J Gastroenterol (2007) 2.77
Diversity of bifidobacteria within the infant gut microbiota. PLoS One (2012) 2.71
S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions. Proc Natl Acad Sci U S A (2008) 2.65
IL-10-dependent partial refractoriness to Toll-like receptor stimulation modulates gut mucosal dendritic cell function. Eur J Immunol (2008) 1.97
Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era. Gastroenterology (2009) 1.96
Effect of enteral nutrition and synbiotics on bacterial infection rates after pylorus-preserving pancreatoduodenectomy: a randomized, double-blind trial. Ann Surg (2007) 1.90
Probiotics and immunity. J Gastroenterol (2009) 1.79
A key role of dendritic cells in probiotic functionality. PLoS One (2007) 1.73
Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius. Immunology (2006) 1.73
Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study. Alcohol (2008) 1.63
Identification of genetic loci in Lactobacillus plantarum that modulate the immune response of dendritic cells using comparative genome hybridization. PLoS One (2010) 1.56
VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice. Hepatology (2009) 1.47
A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells. PLoS One (2010) 1.45
Safety assessment of probiotics for human use. Gut Microbes (2010) 1.44
Retracted Preventative and therapeutic probiotic use in allergic skin conditions: experimental and clinical findings. Biomed Res Int (2013) 1.39
Probiotics-host communication: Modulation of signaling pathways in the intestine. Gut Microbes (2011) 1.38
Dendritic cells at the oral mucosal interface. J Dent Res (2006) 1.24
Immune response to Bifidobacterium bifidum strains support Treg/Th17 plasticity. PLoS One (2011) 1.21
Effects of probiotics on serum levels of Th1/Th2 cytokine and clinical outcomes in severe traumatic brain-injured patients: a prospective randomized pilot study. Crit Care (2011) 1.14
The immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics: proposal of paraprobiotic concept). Genes Nutr (2011) 1.12
Potentially probiotic bacteria induce efficient maturation but differential cytokine production in human monocyte-derived dendritic cells. World J Gastroenterol (2008) 1.11
Dose-dependent immunomodulation of human dendritic cells by the probiotic Lactobacillus rhamnosus Lcr35. PLoS One (2011) 1.11
Selection of probiotic bacteria for prevention of allergic diseases: immunomodulation of neonatal dendritic cells. Clin Exp Immunol (2007) 1.10
Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn's disease. Gut (2005) 1.09
Probiotics, prebiotics and immunomodulation of gut mucosal defences: homeostasis and immunopathology. Nutrients (2013) 1.08
Microbiota/host crosstalk biomarkers: regulatory response of human intestinal dendritic cells exposed to Lactobacillus extracellular encrypted peptide. PLoS One (2012) 1.07
The Effects of Lactobacillus rhamnosus on the Prevention of Asthma in a Murine Model. Allergy Asthma Immunol Res (2010) 1.07
Variable alterations of the microbiota, without metabolic or immunological change, following faecal microbiota transplantation in patients with chronic pouchitis. Sci Rep (2015) 1.03
Various effects of different probiotic strains in allergic disorders: an update from laboratory and clinical data. Clin Exp Immunol (2010) 1.01
Use of probiotics in gastrointestinal disorders: what to recommend? Therap Adv Gastroenterol (2010) 0.99
Immunoregulatory effect of bifidobacteria strains in porcine intestinal epithelial cells through modulation of ubiquitin-editing enzyme A20 expression. PLoS One (2013) 0.99
Evidence for dendritic cell-dependent CD4(+) T helper-1 type responses to commensal bacteria in normal human intestinal lamina propria. Clin Immunol (2009) 0.99
Functional characterization of probiotic surface layer protein-carrying Lactobacillus amylovorus strains. BMC Microbiol (2014) 0.97
Bifidobacterium strains suppress in vitro the pro-inflammatory milieu triggered by the large intestinal microbiota of coeliac patients. J Inflamm (Lond) (2008) 0.96
Intestinal dendritic cells in the pathogenesis of inflammatory bowel disease. World J Gastroenterol (2011) 0.96
Differential interleukin-10 (IL-10) and IL-23 production by human blood monocytes and dendritic cells in response to commensal enteric bacteria. Clin Vaccine Immunol (2012) 0.96
Differential inflammatory mediator response in vitro from murine macrophages to lactobacilli and pathogenic intestinal bacteria. Int J Exp Pathol (2007) 0.95
Gut bacteria in health and disease. Gastroenterol Hepatol (N Y) (2013) 0.95
Updates on treatment of irritable bowel syndrome. World J Gastroenterol (2008) 0.94
Potential regulatory role of microRNAs in the development of bovine gastrointestinal tract during early life. PLoS One (2014) 0.94
The ProPrems trial: investigating the effects of probiotics on late onset sepsis in very preterm infants. BMC Infect Dis (2011) 0.93
Epigenome targeting by probiotic metabolites. Gut Pathog (2010) 0.92
Microbial 'old friends', immunoregulation and socioeconomic status. Clin Exp Immunol (2014) 0.91
Selective effects of Lactobacillus casei Shirota on T cell activation, natural killer cell activity and cytokine production. Clin Exp Immunol (2010) 0.90
Differential modulation of innate immunity in vitro by probiotic strains of Lactobacillus gasseri. BMC Microbiol (2013) 0.89
The C-Type Lectin Receptor SIGNR3 Binds to Fungi Present in Commensal Microbiota and Influences Immune Regulation in Experimental Colitis. Front Immunol (2013) 0.88
Lactobacillus rhamnosus GG and Streptococcus thermophilus induce suppressor of cytokine signalling 3 (SOCS3) gene expression directly and indirectly via interleukin-10 in human primary macrophages. Clin Exp Immunol (2011) 0.88
Probiotics, nuclear receptor signaling, and anti-inflammatory pathways. Gastroenterol Res Pract (2011) 0.88
Effect of the administration of a fermented milk containing Lactobacillus casei DN-114001 on intestinal microbiota and gut associated immune cells of nursing mice and after weaning until immune maturity. BMC Immunol (2008) 0.88
Improved taxonomic assignment of human intestinal 16S rRNA sequences by a dedicated reference database. BMC Genomics (2015) 0.88
Unraveling the ties between irritable bowel syndrome and intestinal microbiota. World J Gastroenterol (2014) 0.88
Probiotic preparation VSL#3 alters the distribution and phenotypes of dendritic cells within the intestinal mucosa in C57BL/10J mice. J Nutr (2009) 0.87
Exploring the influence of the gut microbiota and probiotics on health: a symposium report. Br J Nutr (2014) 0.86
Bacterial signalling overrides cytokine signalling and modifies dendritic cell differentiation. Immunology (2009) 0.86
Inhibitory effects of fermented brown rice on induction of acute colitis by dextran sulfate sodium in rats. Dig Dis Sci (2008) 0.86
Gut microbiota role in irritable bowel syndrome: New therapeutic strategies. World J Gastroenterol (2016) 0.85
Probiotic metabolites from Bacillus coagulans GanedenBC30™ support maturation of antigen-presenting cells in vitro. World J Gastroenterol (2012) 0.85
Gatekeepers of intestinal inflammation. Inflamm Res (2010) 0.85
Bifidobacteria-host interactions--an update on colonisation factors. Biomed Res Int (2014) 0.85
Effects of multispecies probiotic combination on helicobacter pylori infection in vitro. Clin Vaccine Immunol (2008) 0.84
Probiotic modulation of dendritic cell function is influenced by ageing. Immunobiology (2013) 0.84
Probiotic Bio-Three induces Th1 and anti-inflammatory effects in PBMC and dendritic cells. World J Gastroenterol (2010) 0.83
Bifidobacterium longum CCM 7952 Promotes Epithelial Barrier Function and Prevents Acute DSS-Induced Colitis in Strictly Strain-Specific Manner. PLoS One (2015) 0.82
Platform technology to deliver prophylactic molecules orally: an example using the Class A select agent Yersinia pestis. Vaccine (2010) 0.82
From cheese to pharma: a designer probiotic for IBD. Clin Gastroenterol Hepatol (2006) 0.80
Increased Escherichia coli-induced interleukin-23 production by CD16+ monocytes correlates with systemic immune activation in untreated HIV-1-infected individuals. J Virol (2013) 0.79
Allergy Takes Its Toll: The Role of Toll-like Receptors in Allergy Pathogenesis. World Allergy Organ J (2008) 0.79
Th17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel Diseases. Int J Mol Sci (2015) 0.79
Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies. Clin Microbiol Rev (2017) 0.78
Microbiota Manipulation With Prebiotics and Probiotics in Patients Undergoing Stem Cell Transplantation. Curr Hematol Malig Rep (2016) 0.78
The immunopathogenesis of cow's milk protein allergy (CMPA). Ital J Pediatr (2012) 0.78
Antibodies to Lactobacilli and Bifidobacteria in young children with different propensity to develop islet autoimmunity. J Immunol Res (2014) 0.78
Immunomodulatory activity of two potential probiotic strains in LPS-stimulated HT-29 cells. Genes Nutr (2014) 0.77
Identification and molecular characterization of oat peptides implicated on coeliac immune response. Food Nutr Res (2016) 0.77
Gut Catalase-Positive Bacteria Cross-Protect Adjacent Bifidobacteria from Oxidative Stress. Microbes Environ (2015) 0.77
Alternative medicines as emerging therapies for inflammatory bowel diseases. Int Rev Immunol (2012) 0.77
The Probiotic Mixture VSL#3 Alters the Morphology and Secretion Profile of Both Polarized and Unpolarized Human Macrophages in a Polarization-Dependent Manner. J Clin Cell Immunol (2014) 0.77
Transcriptome analysis reveals regional and temporal differences in mucosal immune system development in the small intestine of neonatal calves. BMC Genomics (2016) 0.77
Prebiotics, probiotics, synbiotics in surgery--are they only trendy, truly effective or even dangerous? Langenbecks Arch Surg (2008) 0.76
Intestinal dendritic cells change in number in fulminant hepatic failure. World J Gastroenterol (2015) 0.76
Gut Microbiota and Immunity: Possible Role in Sudden Infant Death Syndrome. Front Immunol (2015) 0.76
Potential Benefits of Dietary Fibre Intervention in Inflammatory Bowel Disease. Int J Mol Sci (2016) 0.76
Safety and protective effectiveness of two strains of Lactobacillus with probiotic features in an experimental model of salmonellosis. Int J Environ Res Public Health (2014) 0.75
Erythromycin treatment hinders the induction of oral tolerance to fed ovalbumin. Front Immunol (2012) 0.75
In vitro and in vivo survival and colonic adhesion of Pediococcus acidilactici MTCC5101 in human gut. Biomed Res Int (2013) 0.75
Stimulation of PBMC and Monocyte-Derived Macrophages via Toll-Like Receptor Activates Innate Immune Pathways in HIV-Infected Patients on Virally Suppressive Combination Antiretroviral Therapy. Front Immunol (2016) 0.75
Oral administration of Lactobacillus paracasei L9 attenuates PM2.5-induced enhancement of airway hyperresponsiveness and allergic airway response in murine model of asthma. PLoS One (2017) 0.75
Inhibition of neddylation regulates dendritic cell functions via Deptor accumulation driven mTOR inactivation. Oncotarget (2016) 0.75
Probiotics and barrier function in colitis. Gut (2005) 0.75
Diversity: from diet to flora to life. Glob Adv Health Med (2014) 0.75
Lactobacillus johnsonii supplementation attenuates respiratory viral infection via metabolic reprogramming and immune cell modulation. Mucosal Immunol (2017) 0.75
Oral administration of lactobacilli isolated from Jeotgal, a salted fermented seafood, inhibits the development of 2,4-dinitrofluorobenzene-induced atopic dermatitis in mice. Exp Ther Med (2017) 0.75
Effects of Non-Starch Polysaccharides on Inflammatory Bowel Disease. Int J Mol Sci (2017) 0.75
Dendritic cells and the control of immunity. Nature (1998) 56.54
A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature (1997) 16.28
Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol (2001) 11.07
An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med (1999) 10.67
Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. Immunity (1994) 9.63
Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med (1996) 9.31
Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med (2001) 8.60
Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci U S A (2002) 6.19
Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science (2000) 6.19
Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J Immunol (1995) 6.09
Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet (1999) 5.36
Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology (2000) 5.34
Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol (2001) 5.11
Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol (2002) 4.64
Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology (2001) 4.44
Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology (2003) 4.40
Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J Immunol (2002) 3.79
Freshly isolated Peyer's patch, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells. J Exp Med (1999) 3.79
Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect Immun (2001) 3.55
Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther (1997) 3.02
Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans. Implications for initiation of T helper cell immunity in vitro and in vivo. J Exp Med (2000) 2.99
Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo. J Immunol (2001) 2.64
Intestinal dendritic cells increase T cell expression of alpha4beta7 integrin. Eur J Immunol (2002) 2.45
Expanding dendritic cells in vivo enhances the induction of oral tolerance. J Immunol (1998) 2.01
The dendritic cell: its role in intestinal inflammation and relationship with gut bacteria. Gut (2003) 1.84
Migration and maturation of human colonic dendritic cells. J Immunol (2001) 1.64
CD40 ligation counteracts Fas-induced apoptosis of human dendritic cells. Int Immunol (1997) 1.44
Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: effects of probiotic treatment. Am J Gastroenterol (2001) 1.43
What's the difference between CD80 and CD86? Trends Immunol (2003) 1.29
Intracellular cytokine production by human CD4+ and CD8+ T cells from normal and immunodeficient donors using directly conjugated anti-cytokine antibodies and three-colour flow cytometry. Clin Exp Immunol (1996) 1.24
Hyperexpression of CD40 ligand (CD154) in inflammatory bowel disease and its contribution to pathogenic cytokine production. J Immunol (1999) 1.20
Effect of probiotic strains on interleukin 8 production by HT29/19A cells. Am J Gastroenterol (2002) 1.15
Regulation of mucosal dendritic cell function by receptor activator of NF-kappa B (RANK)/RANK ligand interactions: impact on tolerance induction. J Immunol (2002) 1.13
Activation of human peripheral blood dendritic cells induces the CD86 co-stimulatory molecule. Eur J Immunol (1995) 1.12
The prevention and treatment of murine colitis using gene therapy with adenoviral vectors encoding IL-10. J Immunol (2001) 1.09
Stimulation of the secretion of pro-inflammatory cytokines by Bifidobacterium strains. Microbiol Immunol (2002) 1.07
Retrovirally induced switch from production of IL-12 to IL-4 in dendritic cells. Eur J Immunol (1999) 1.05
Quantification and cytokine production of circulating lymphoid and myeloid cells in acute myelogenous leukaemia. Leukemia (2003) 1.04
Preferential induction of IL-10 in APC correlates with a switch from Th1 to Th2 response following infection with a low pathogenic variant of Theiler's virus. J Immunol (2002) 0.99
Rat bone marrow-derived dendritic cells, but not ex vivo dendritic cells, secrete nitric oxide and can inhibit T-cell proliferation. Immunology (2003) 0.98
Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. J Immunol (2001) 7.43
Persistent pain and faecal urgency after stapled haemorrhoidectomy. Lancet (2000) 7.09
Anal-sphincter disruption during vaginal delivery. N Engl J Med (1993) 5.74
Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology (2000) 5.34
Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. Functional and morphological studies. J Exp Med (1987) 5.14
Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut (2004) 3.80
European evidence based consensus on the diagnosis and management of Crohn's disease: current management. Gut (2006) 3.59
Prospective comparison of faecal incontinence grading systems. Gut (1999) 3.48
Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med (1996) 3.47
Dendritic cells and the initiation of contact sensitivity to fluorescein isothiocyanate. Immunology (1986) 3.25
Primary stimulation by dendritic cells induces antiviral proliferative and cytotoxic T cell responses in vitro. J Exp Med (1989) 3.16
Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut (2004) 3.01
Third degree obstetric anal sphincter tears: risk factors and outcome of primary repair. BMJ (1994) 2.75
Non-adherent, low-density cells from human peripheral blood contain dendritic cells and monocytes, both with veiled morphology. Immunology (1986) 2.72
Identification of hematopoietic progenitors of macrophages and dendritic Langerhans cells (DL-CFU) in human bone marrow and peripheral blood. Blood (1990) 2.68
Induction of immune responses in vivo with small numbers of veiled (dendritic) cells. Proc Natl Acad Sci U S A (1983) 2.68
Dendritic cell infection, depletion and dysfunction in HIV-infected individuals. Immunology (1990) 2.58
Role of veiled cells in lymphocyte activation. Eur J Immunol (1982) 2.50
Macrophage subpopulations in lamina propria of normal and inflamed colon and terminal ileum. Gut (1989) 2.44
The role of dendritic cells in the initiation of immune responses to contact sensitizers. I. In vivo exposure to antigen. Cell Immunol (1985) 2.43
Randomised controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohn's disease. Lancet (1997) 2.38
Susceptibility of human peripheral blood dendritic cells to infection by human immunodeficiency virus. J Gen Virol (1987) 2.38
Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis. Aliment Pharmacol Ther (1999) 2.26
Adalimumab for the treatment of fistulas in patients with Crohn's disease. Gut (2009) 2.20
AGA technical review on anorectal testing techniques. Gastroenterology (1999) 2.05
Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease. Lancet (1994) 2.04
A comparison of Plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model. Vaccine (1995) 2.03
Treatment of ulcerative colitis with high-dose 5-aminosalicylic acid enemas. Lancet (1981) 2.02
Human peripheral blood contains two distinct lineages of dendritic cells. Eur J Immunol (1999) 2.01
Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience. Gut (1993) 2.01
Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFN-gamma production. J Immunol (1993) 2.00
Diagnosis and treatment of chronic constipation--a European perspective. Neurogastroenterol Motil (2011) 1.99
Bacteria as the cause of ulcerative colitis. Gut (2001) 1.96
Veiled cells--"dendritic cells" of the peripheral lymph. Immunobiology (1984) 1.86
Systematic review of sacral nerve stimulation for faecal incontinence and constipation. Br J Surg (2004) 1.84
The dendritic cell: its role in intestinal inflammation and relationship with gut bacteria. Gut (2003) 1.84
Long-term clinical outcome of surgery for solitary rectal ulcer syndrome. Br J Surg (1998) 1.80
Engagement of CD27 with its ligand CD70 provides a second signal for T cell activation. J Immunol (1995) 1.79
Pilot study of two new injectable bulking agents for the treatment of faecal incontinence. Colorectal Dis (2007) 1.78
Mechanisms of action of probiotics: recent advances. Inflamm Bowel Dis (2009) 1.75
Permanent sacral nerve stimulation for treatment of idiopathic constipation. Br J Surg (2002) 1.75
Response to a behavioural treatment, biofeedback, in constipated patients is associated with improved gut transit and autonomic innervation. Gut (2001) 1.75
Bowel dysfunction in spinal-cord-injury patients. Lancet (1996) 1.74
Evaluation of Helicobacter species in inflammatory bowel disease. Aliment Pharmacol Ther (2003) 1.73
Genetic analysis of inflammatory bowel disease in a large European cohort supports linkage to chromosomes 12 and 16. Gastroenterology (1998) 1.73
Long-term results of overlapping anterior anal-sphincter repair for obstetric trauma. Lancet (2000) 1.72
Clinical characteristics of chronic idiopathic intestinal pseudo-obstruction in adults. Gut (1997) 1.71
Radioisotope determination of regional colonic transit in severe constipation: comparison with radio opaque markers. Gut (1993) 1.71
A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague. Vaccine (1997) 1.70
Antibodies to tumour necrosis factor alpha as treatment for Crohn's disease. Lancet (2000) 1.69
Enhanced mucosal interleukin-6 and -8 in Helicobacter pylori-positive dyspeptic patients. Am J Gastroenterol (1994) 1.69
Haemorrhoids: pathology, pathophysiology and aetiology. Br J Surg (1994) 1.67
Conditions for measuring DNA synthesis in PHA stimulated human lymphocytes in 20 microliters hanging drops with various cell concentrations and periods of culture. J Immunol Methods (1980) 1.66
Migration and maturation of human colonic dendritic cells. J Immunol (2001) 1.64
The burden of constipation on quality of life: results of a multinational survey. Aliment Pharmacol Ther (2007) 1.64
Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk. Gut (2004) 1.63
The role of dendritic cells in the initiation of immune responses to contact sensitizers. II. Studies in nude mice. Cell Immunol (1985) 1.62
Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis. Am J Pathol (1999) 1.62
Infliximab in the treatment of Crohn's disease: predictors of response in an Italian multicentric open study. Dig Liver Dis (2005) 1.61
Randomized controlled trial of topical phenylephrine in the treatment of faecal incontinence. Br J Surg (2000) 1.61
Failure in antigen responses by T cells from patients with common variable immunodeficiency (CVID). Clin Exp Immunol (1994) 1.61
Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production. Int J Food Microbiol (2008) 1.61
Suppression of immune responses by dendritic cells infected with HIV. Immunology (1989) 1.61
Gastrointestinal hormones in short bowel syndrome. Peptide YY may be the 'colonic brake' to gastric emptying. Gut (1996) 1.60
Efficacy of doxycycline and ciprofloxacin against experimental Yersinia pestis infection. J Antimicrob Chemother (1998) 1.60
Exceptional lymphocyte stimulating capacity of cells from lymphoid cell lines. Nature (1969) 1.60
Steroid treatment in active Crohn's disease: a comparison between two regimens of different duration. Aliment Pharmacol Ther (1994) 1.59
An engineered human antibody to TNF (CDP571) for active Crohn's disease: a randomized double-blind placebo-controlled trial. Gastroenterology (2001) 1.57
'Reversible chemical sphincterotomy' by local application of glyceryl trinitrate. Br J Surg (1994) 1.55
Immunologic reactivity in rheumatoid arthritis. Response to mitogens. Arthritis Rheum (1974) 1.52
Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration. Kidney Int (2001) 1.51
Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study. Gut (2005) 1.49
Controlled study using wireless capsule endoscopy for the evaluation of the small intestine in chronic refractory pouchitis. Aliment Pharmacol Ther (2007) 1.49
A multinational survey of prevalence and patterns of laxative use among adults with self-defined constipation. Aliment Pharmacol Ther (2008) 1.49
Solitary rectal ulcer syndrome. Br J Surg (1998) 1.48
Internal anal sphincter repair. Int J Colorectal Dis (1997) 1.47
Gender differences in the longitudinal pressure profile of the anal canal related to anatomical structure as demonstrated on three-dimensional anal endosonography. Br J Surg (2000) 1.46